MYOCD and pulmonary fibrosis: Snitow reported that EZH2 loss reduces the expression of myocardin and TBX18, thereby affecting the autonomic inhibition of smooth muscle differentiation in mesothelium cells, and ultimately contributing to the development of COPD and idiopathic pulmonary fibrosis [35].